Oral corticosteroid-related adverse events cost UK £84 million

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.585, 2009-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Corticosteroid-related AEs come at high cost in SLE

Reactions Weekly, Vol. 1, Iss. 1381, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Safety of Inhaled Budesonide: Clinical Manifestations of Systemic Corticosteroid-Related Adverse Effects

By Christensson Camilla Thorén Anders Lindberg Bengt

Drug Safety, Vol. 31, Iss. 11, 2008-01 ,pp. : 965-988

Adis International

Access to resources Recommend Favorite

Preventable adverse events cost UK NHS dearly

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 303, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Corticosteroid-Induced Adverse Events in Adults: Frequency, Screening and Prevention

By Fardet Laurence Kassar Abdulrhaman

Drug Safety, Vol. 30, Iss. 10, 2007-01 ,pp. : 861-881

Adis International

Access to resources Recommend Favorite

Adverse events increase cost of CML treatment

Inpharma, Vol. 1, Iss. 1572, 2007-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite